First Mercantile Trust’s bluebird bio BLUE Stock Holding History

First Mercantile Trust’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-190	Closed	-$438K	–	767
2017 Q4	$438K	Sell	190 -8	-4%	-$16.2K	0.09%	290
2017 Q3	$353K	Buy	198 +89	+82%	+$124K	0.06%	391
2017 Q2	$148K	Sell	109 -115	-51%	-$139K	0.03%	637
2017 Q1	$263K	Buy	224 +29	+15%	+$29.6K	0.04%	524
2016 Q4	$156K	Buy	195 +48	+33%	+$38.1K	0.02%	635
2016 Q3	$129K	Buy	+147	New	+$106K	0.02%	681
2015 Q2	–	Sell	-178	Closed	-$279K	–	982
2015 Q1	$279K	Buy	178 +7	+4%	+$9.24K	0.02%	643
2014 Q4	$203K	Buy	+171	New	+$114K	0.02%	678
2014 Q3	–	Sell	-122	Closed	-$61K	–	1139
2014 Q2	$61K	Buy	+122	New	+$39.1K	﹤0.01%	907

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

First Mercantile Trust's BLUE Position: Q1 2018 in Review

First Mercantile Trust sold out of bluebird bio (BLUE) in Q1 2018, closing a stake of 190 shares — an estimated $438K sold.

First Mercantile Trust first reported a position in BLUE in Q2 2014 and held it in 9 quarters. The position peaked at $438K in Q4 2017. 303 funds tracked by Wall St. Rank hold BLUE as of Q1 2018.

First Mercantile Trust reported no remaining bluebird bio position as of Q1 2018 after selling out during the quarter.
First Mercantile Trust sold 190 bluebird bio shares in Q1 2018, an estimated $438K.
First Mercantile Trust first reported a position in bluebird bio in Q2 2014 and held it in 9 quarters.
First Mercantile Trust's bluebird bio position peaked at $438K in Q4 2017.
303 funds tracked by Wall St. Rank held bluebird bio as of Q1 2018.

Based on First Mercantile Trust's 13F filing for Q1 2018, filed 8 May 2018.